679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

• Siqing Fu,
• Rom S Leidner,
• Ki Chung,
• Jiaxin Niu,
• Ilian Tchakov,
• Debra L Richardson,
• Xiaoping Qing,
• Jorge Nieva,
• Douglas Adkins,
• Alan L Ho,
• Minh Phan,
• Alexander T Pearson,
• Marshall R Posner,
• Lisle Nabell,
• Stuart Wong,
• Katerin Rojas,
• Ari J Rosenberg,
• Trisha Kaufmann,
• Christopher Plescia,
• Corinne Iacobucci,
• Kia Katchar,
• Klaus Orlinger,
• Katia Schlienger,
• David G Pfister

Affiliations

Siqing Fu

4The University of Texas – MD Anderson Cancer Center, Medical Oncology, Houston, USA

Rom S Leidner

Aff1 grid.415286.cEarle A. Chiles Research Institute Portland OR USA

Ki Chung

Aff2 grid.413319.d0000000404067499GHS Cancer Institute Spartanburg SC USA

Jiaxin Niu

7Banner MD Anderson Cancer Center, Gilbert, AZ, USA

Ilian Tchakov

10 Eisai, Hatfield, UK

Debra L Richardson

6 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

Xiaoping Qing

1Program in Inflammation and Autoimmunity, Hospital for Special Surgery, USA

Jorge Nieva

13University of Southern California, Norris Cancer Center, Los Angeles, CA, USA

Douglas Adkins

8Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Saint Louis, MO, USA

Alan L Ho

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Minh Phan

6Sarah Cannon Research Institute at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

Alexander T Pearson

3University of Chicago, Department of Medicine, Chicago, IL, USA

Marshall R Posner

5Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA

Lisle Nabell

7University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA

Stuart Wong

14Medical College of Wisconsin, Milwaukee, WI, USA

Katerin Rojas

15Vall D’Hebron University Hospital, Vall D’Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Spain

Ari J Rosenberg

16University of Chicago Medicine, Chicago, IL, USA

Trisha Kaufmann

18Hookipa Pharma Inc., New York, NY, USA

Christopher Plescia

18Hookipa Pharma Inc., New York, NY, USA

Corinne Iacobucci

18Hookipa Pharma Inc., New York, NY, USA

Kia Katchar

18Hookipa Pharma Inc., New York, NY, USA

Klaus Orlinger

18Hookipa Pharma Inc., New York, NY, USA

Katia Schlienger

18Hookipa Pharma Inc., New York, NY, USA

David G Pfister

1Memorial Sloan Kettering Cancer Center, New York, NY, USA